In vitro evolution of enhanced RNA replicons for immunotherapy

Yingzhong Li(Mabvax Therapeutics (United States)), Ron Weiss(Massachusetts Institute of Technology)
Scientific Reports
May 6, 2019
Cited by 75


Related Papers